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Introduction
Systemic lupus erythematosus (SLE [MIM 152700] [1]) is
an autoimmune disease characterized by the production of
autoantibodies with specificity for a wide range of self-
antigens. These antibodies cause disease directly by
binding to target tissues (e.g. platelets and phospho-
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Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by the production
of autoantibodies to a wide range of self-antigens. Recent genome screens have implicated numerous
chromosomal regions as potential SLE susceptibility loci. Among these, the 1q41 locus is of particular
interest, because evidence for linkage has been found in several independent SLE family collections.
Additionally, the 1q41 locus appears to be syntenic with a susceptibility interval identified in the
NZM2410 mouse model for SLE. Here, we report the results of genotyping of 11 microsatellite
markers within the 1q41 region in 210 SLE sibpair and 122 SLE trio families. These data confirm the
modest evidence for linkage at 1q41 in our family collection (LOD = 1.21 at marker D1S2616).
Evidence for significant linkage disequilibrium in this interval was also found. Multiple markers in the
region exhibit transmission disequilibrium, with the peak single marker multiallelic linkage disequilibrium
noted at D1S490 (pedigree disequilibrium test [PDT] global P value = 0.0091). Two- and three-marker
haplotypes from the 1q41 region similarly showed strong transmission distortion in the collection of
332 SLE families. The finding of linkage together with significant transmission disequilibrium provides
strong evidence for a susceptibility locus at 1q41 in human SLE.
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lipids), and indirectly by depositing immune complexes in
vascular tissues, leading to organ damage [2]. The current
evidence suggests that SLE is a complex genetic disease,
with contributions from both environmental (e.g. ultraviolet
light, viral infections) and genetic factors.
A number of recent genome-wide screens support the
genetic hypothesis in human SLE, and have reported, in
aggregate, 48 potential susceptibility loci [3–7] (reviewed
[8]). Of these intervals, significant attention has been
directed at the 1q41–42 chromosomal region. After the
identification of the syntenic region in mouse (Sle1) as a
susceptibility interval for murine SLE [9], a targeted study
by Tsao et al [10] was the first to implicate this locus in
human SLE (marker D1S229; P < 0.005). Subsequently,
two independent SLE genome scans also found sugges-
tive evidence for linkage at 1q41–42 [3–5]. Poly ADP
ribosyl polymerase (PARP; also referred to as ADPRT
[adenosine diphosphate ribosyltransferase]) was initially
suggested as the relevant candidate gene in the region
[11,12], but that finding was not reproduced in other
family collections [13].
The work of Moser et al [14] provided the initial evidence
that the susceptibility locus in this region might lie cen-
tromeric of PARP. In 127 multiplex SLE pedigrees, the
best evidence for linkage was at D1S229, with the great-
est extent of allele sharing in the white families at the
D1S2616 marker. The data reported here confirm the evi-
dence for genetic linkage at 1q41 in 210 SLE sibpair fam-
ilies (families with a pair of affected sibs) from the
Minnesota collection [3,4]. Furthermore, we report new
evidence for transmission disequilibrium of both single
marker alleles and short marker haplotypes from the
1q41–42 interval in 122 trio families (families with a single
affected offspring and both parents) and in the total
dataset of 332 SLE families. These data suggest that a
human SLE susceptibility locus is located centromeric to
PARP near the D1S490 marker.
Materials and methods
SLE family collection
The collection of 187 affected sibpair families in Cohorts
1 and 2 of the Minnesota collection have been described
in detail elsewhere [3,4]. An additional group of 24 sibpair
families was collected and members were genotyped for
the 11 markers in the 1q41–42 region. One hundred and
twenty-two trio families were also collected. This study
was approved by the Human Subjects Review Board at
the Mayo Clinic and at the University of Minnesota. The
clinical features of the sibpair and trio families are pro-
vided in the Supplementary material.
Samples and genotyping
Genomic DNA isolation and genotyping of families was
performed as described [3,4]. The 12 markers from the
1q41–42 region originally typed by Moser et al [14] were
typed in the Minnesota collection. Marker order (Fig. 1)
was determined using the public databases described in
the Supplementary material.
Data analysis
See Supplementary material for details of linkage analysis
and transmission disequilibrium testing.
Results
Genetic linkage in the 1q41–42 region
In the combined data from the original Cohorts 1 and 2
genome screens, the highest LOD score in the 1q41–42
region was 1.33 at marker D1S229 [4]. With the addition
of five new fine-map markers and 24 new families, the best
evidence for linkage was slightly reduced (LOD = 1.23)
and shifted telomeric to marker D1S2616 (Fig. 2). This
level of linkage support corresponds roughly to a nominal
P value of 0.05. When only white families were consid-
ered, the peak multipoint LOD score remained at marker
D1S2616 (LOD = 0.99; Fig. 2).
Transmission disequilibrium in the 1q41–42 region
The standard transmission disequilibrium test (TDT) [15],
applied to the data for a single marker allele, failed to iden-
tify significant transmission disequilibrium (Fig. 3). Analyses
with the C-TDT (the TDT combined with the discordant sib
TDT [S-TDT]), which allows additional families containing
discordant sibs to be evaluated for disequilibrium [16],
were then performed. Among the 60 families with discor-
dant siblings but missing parental information, several
microsatellite alleles in the 1q41 region demonstrated sig-
nificant evidence of transmission disequilibrium (Fig. 3).
Markers D1S490-allele 6 (P = 0.0044), D1S229–allele 7
(P = 0.0054), and D1S227–allele 5 (P = 0.0084) showed
the strongest evidence for disequilibrium using the C-TDT.
The TDT and C-TDT are limited by the fact that only one
triad or discordant sibship is analyzed from a given
family; thus these two tests examine only a subset of the
data from general pedigrees. The pedigree disequilib-
rium test (PDT) improves upon these two tests by gener-
ating a measure of linkage disequilibrium for every
discordant sibship and triad in a pedigree [17]. Because
it examines the entire data set, the PDT can result in
much higher power than the other two tests [17]. The
version of the PDT used in this analysis has been modi-
fied to accept dyads (a single typed parent and an
affected offspring). A dyad is informative only when the
offspring has a heterozygous genotype different from
that of the parent, thus avoiding the bias of using
inferred phase assignments [18,19]. Using the PDT,
three single marker alleles of D1S490 exhibited evi-
dence of transmission disequilibrium (Fig. 3). Consistent
with the C-TDT results, D1S490-allele 6 yielded the
strongest PDT result (P = 0.0071).Transmission disequilibrium of marker haplotypes in
the 1q41–42 region
Two- and three-marker haplotypes from the 1q41–42
region were next tested for evidence of transmission dis-
equilibrium (Fig. 3). Haplotype clusters were generated for
‘exact match’ haplotypes with more than 10 founders.
Analysis of two- and three-marker haplotypes revealed that
haplotypes from D1S490 to D1S549 had the greatest
number of transmissions and yielded the most significant P
values, with the majority of the significant haplotypes cen-
tered on D1S227. The two-marker haplotypes D1S425–
allele 10/D1S2827–allele 11, D1S490–allele 7/D1S227–
allele 5, and D1S2616–allele 6/D1S549–allele 12 were
significant in the TDT, C-TDT, and PDT. The D1S490–allele
7/D1S227–allele 5 and D1S2616–allele 6/D1S549–allele
12 haplotypes had 63% (42:25) and 61% (52:33) transmit-
ted:nontransmitted ratios (T:NT), respectively.
Using three-marker haplotypes, the strongest evidence for
disequilibrium was in the region spanning the markers
D1S229 to D1S2641. Notably, the D1S229–allele 7/
D1S490–allele 7/D1S227–allele 5 (T:NT = 23:6, 79% T)
and the D1S2616–allele 6/D1S549–allele 12/D1S2641–
allele 10 (T:NT = 18:6, 75% T) haplotypes yielded biallelic
PDT P values of < 0.008.
Global multiallelic disequilibrium statistic
The PDT test also calculates a measure of the linkage dis-
equilibrium for all the alleles of a given marker in the form
of a global multiallelic P value. Using this statistic, the 11
markers of 1q32–42 fine map were tested for global
transmission disequilibrium (Fig. 4). Importantly, two
markers in the 1q32–42 region reach the 0.05 level of sig-
nificance in the data set from the 332 SLE families.
D1S425 results in a global P value of 0.034, which
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Figure 1
Genetic and physical maps of the 1q32–42 region. The genetic map is based on the maps available at Marshfield, WI, USA
(http://research.marshfieldclinic.org/genetics) and the Genome Database (http://www.gdb.org). The physical map was determined from the
sequence data generated by the Human Genome Project (as described in the text), and is available from the National Center for Biotechnology
Information (http://www.ncbi.nlm.nih.gov). The physical distance between the markers was estimated from the available sequence data if the markers
were not on the same contig, and the maps are not drawn to scale. The physical location of D1S213 between D1S2641 and ADPRT is not known.appeared to be largely driven by the contribution of fami-
lies in the trio collection (P = 0.0056). D1S490 showed
the most significant result using this test (P = 0.0091),
with both the sibpair and trio collections contributing to
the linkage disequilibrium observed. Significant results for
this global disequilibrium statistic were not observed for
any other markers in the 1q41–42 region, including
ADPRT (PARP). Two- and three-marker haplotype analysis
with the global PDT identified only one significant result.
The D1S425–D1S2827 ‘window’ yielded a PDT global P
value of 0.032.
Discussion
The localization of genes in complex genetic diseases is a
challenging proposition, given that these disorders are
likely to show significant locus heterogeneity, genetic
epistasis, and incomplete penetrance, as well as environ-
mental effects. In SLE, all the available evidence points to
a similarly complex genetic etiology, with six recent
genetic linkage studies implicating as many as 48 genetic
loci [3–7,20]. While some of the loci identified are likely to
be false positives or relatively minor genes enriched in one
population or another, the locus at 1q41 is unique in that it
has provided a significant, though modest, linkage signal
in three independent SLE populations [3-5,10,14]. Fine-
mapping in the 1q41 region by Moser et al [14] also
showed that the highest overall LOD score in 127 families
of the Oklahoma collection was at D1S229, and the great-
est degree of allele sharing in 78 white families was at
D1S2616. D1S229 also showed the strongest evidence
for linkage in the UCLA collection [10], and was the best
marker in genome screens performed on the Minnesota
family collection [3,4]. Thus, the evidence for linkage at
1q41 is reproducible in independent collections using the
identical markers.
To detect association with SLE, we used the transmission
disequilibrium test (TDT), as well as two additional tests,
the C-TDT and the PDT. The PDT is the strongest test of
association because of its ability to maximize the informa-
tion extracted from complex pedigrees. Importantly, marker
D1S490 in the 1q41 region was significant on the multi-
allelic PDT (Fig. 4). Supporting the global finding, the C-
TDT and PDT tests also identified evidence for
transmission disequilibrium with several alleles from
D1S490 and nearby markers (Fig. 3). Marker D1S425 in
the 1q32 region also demonstrated significant transmis-
sion disequilibrium, particularly in the trio collection (Fig. 4).
We sought to confirm and expand upon the results of the
single-marker tests by examining haplotypes from the
1q32–41 region for the presence of transmission disequi-
librium. Haplotype-based association methods may be
more powerful than single-marker tests [21–23]. For
example, the same microsatellite allele (i.e. same size
microsatellite repeat) may be present on a number of hap-
lotypes, some of which may not be associated with
disease. Indeed, haplotype-based association methods
employing a dense map of markers have been used to
localize genetic effects to small segments of chromosomes
[24–29]. The knowledge of marker order and intermarker
distances in the 1q41 region allowed the generation of
haplotypes with unambiguously determined ‘phase’ in our
large collection of SLE families. The D1S425–D1S2827
two-marker haplotype window in the 1q32 region showed
evidence for transmission disequilibrium via the global
PDT, while no other windows showed evidence of associa-
tion using this multiallelic test. However, several individual
two- and three-marker haplotypes from the 1q32 and 1q41
region showed significant transmission disequilibrium
(Fig. 3). These haplotype results should be viewed with
some caution, since they are uncorrected for the multiple
allele combinations tested, and the possibility of Type I
errors may be increased.
At present, the most interesting candidate gene in the
region showing the strongest evidence for disequilibrium is
the estrogen-related receptor gamma (ESRRG). This gene
is found on the same contig as D1S490 (NT_004817) and
is an orphan receptor within the steroid hormone receptor
superfamily. It is expressed in lymphocytes and other
Arthritis Research    Vol 3 No 5 Graham et al
Figure 2
Linkage in the 1q41 region. GENEHUNTER PLUS (see reference [S4]
of supplementary material) was used to perform multipoint
nonparametric linkage analysis using the 11 markers shown in the total
collection of 210 families with systemic lupus erythematosus and in a
subset of 163 white families. Marker positions (cM) were estimated
based on the available genetic and physical maps.Available online http://arthritis-research.com/content/3/5/299
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Figure 3
Transmission disequilibrium of individual alleles and short marker haplotypes in the 1q32–42 region. Single-allele and two- or three-marker
haplotype data sets were analyzed using the transmission disequilibrium test (TDT), the combined TDT and discordant-sib TDT (C-TDT), and the
pedigree disequilibrium test (PDT). For the single-marker data, the entire collection of 332 families with systemic lupus erythematosus was used,
while the two- and three-marker analyses were performed only on the 274 families with at least one typed parent. Only those marker alleles or
haplotypes with at least one significant result are shown.
Figure 4
Global pedigree disequilibrium test at 1q32–42 in 332 families with systemic lupus erythematosus. The global (multiallelic) P values found using
the pedigree disequilibrium test are graphed for each of the 11 markers that comprised the fine map. The ‘All Families’ data are graphed in the left
panel.tissues and is an interesting candidate, given the sus-
pected role of sex hormones in the pathophysiology of
both mouse and human lupus [30,31]. Other genes in the
region include those for the cathelicidin antimicrobial
peptide (near D1S2616), an innate microbial defense
peptide expressed by the skin during inflammation; MARK
(near D1S2641), a serine/threonine protein kinase; and at
least three uncharacterized genes.
The data reported here provide some additional perspec-
tive on the initial reports that PARP might be the relevant
gene in this locus. The finding of significant transmission
distortion of marker alleles centromeric to PARP in the
Minnesota collection suggests the possibility that the dise-
quilibrium initially reported for PARP alleles may be due to
more extensive disequilibrium – to include the PARP
marker – in the families studied by Tsao and her col-
leagues compared with other populations and groups of
families studied. A dense mapping of this interval by all the
various groups and a pooling of data would help to resolve
this question. It seems likely that, as in the HLA region
[32], there will be a limited number of ancestral haplotypes
in the 1q41 region, and that these ancestral haplotypes
will be identifiable by typing a dense map of microsatel-
lites. This should facilitate the identification of the respon-
sible gene(s) in the region.
Conclusions
The data reported here confirm the evidence for genetic
linkage at 1q41 in 210 SLE sibpair families from the Min-
nesota collection. Furthermore, we report new evidence
for transmission disequilibrium of both single marker
alleles and short marker haplotypes from the 1q41–42
interval in 122 trio families and in the total dataset of 332
SLE families. These data suggest that a human SLE sus-
ceptibility locus is located centromeric to PARP near the
D1S490 marker.
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Supplementary material
Supplementary materials and methods
Establishing marker order in the 1q41–42 region
The 12 markers from the 1q41–42 region originally typed
by Moser et al [S1] were typed in the Minnesota collec-
tion (see Fig. 1 in the main text of this article). Genetic
maps for the region were obtained from the Marshfield
Clinic (Marshfield, WI, USA; http://research.marshfield-
clinic.org/genetics) and the Genome Database
(http://www.gdb.org). Since genetic maps have limited
resolution in the case of closely linked markers, the avail-
able human genomic sequence from the region was ana-
lyzed to more accurately assess marker order and
intermarker distances. The Human Genome Project
Working Draft database (based on October 7, 2000
freeze) at the University of California, Santa Cruz
(http://genome.ucsc.edu), was the primary source used to
establish marker order. Three markers (D1S425, D1S229,
and D1S213) could not be located in this database. The
UniSTS database (http://www.ncbi.nlm.nih.gov/genome/
sts/epcr.cgi) located D1S425 on contig NT_004656.
According to Mapviewer tool on the National Center for
Biotechnology Information site (http://www.ncbi.nlm.nih.
gov/genome/guide/human), D1S425 lies 4 Mb telomeric
of D1S245. BLAST (http://www.ncbi.nlm.nih.govb/
BLAST/) analysis of the human genome sequence was
used to locate D1S229 on the contig NT_004817,
125 kb centromeric of D1S490. D1S2860 was found to
map to chromosome 3 and thus was omitted from the
present analysis. Only 1 marker, D1S213, was not located
on any assembled contigs or draft sequence.
Samples and genotyping
Panels of markers were optimized such that markers
bearing the same fluorescent tag could be multiplexed in
polymerase chain reaction (PCR). PCR (32 cycles) was
performed on an ABI 877 Catalyst robotic workstation
(5 µl reactions – 5 ng of genomic DNA, 2.5 mM MgCl2,
0.2 mM dNTPs [Pharmacia, Piscataway, NJ, USA], 0.2 U
Amplitaq Gold DNA polymerase [Perkin-Elmer, Foster
City, CA, USA] in 1 × PCR Buffer II [Perkin-Elmer]). Indi-
vidual primer-pair concentrations ranged from 0.31 to
3.30 pmol per reaction, based on the results of optimiza-
tion runs. Pooled amplification products were elec-
trophoresed through 5% polyacrylamide gels (FMC
Bioproducts, Rockland, ME, USA) for 2 h at 3000 V on an
ABI 377 DNA Sequencer. Semiautomated fragment sizing
was performed using GENESCAN software (v. 2.1, ABI,
Foster, CA, USA) followed by allele calling with GENO-
TYPER software (v. 2.5, ABI).
Data verification
Each genotype was reviewed manually by two members of
the team to confirm the accuracy of allele calling. The
genotype data from the 11 microsatellites used in the
study were analyzed using PEDCHECK and RELATIVE to
identify errors in Mendelian inheritance and to confirm
familial relationships [S2,S3]. Additionally, the maximum-
likelihood haplotypes for each pedigree (generated by
GENEHUNTER PLUS [S4], a modified version of GENE-
HUNTER [S5]) were examined to identify multiple recom-
binants. Double recombinants were generally found to be
genotyping errors and were corrected.
Linkage analysis
Multipoint nonparametric linkage analysis was performed
using GENEHUNTER PLUS [S4]. We report the results
based on the Sall scoring function, which emphasizes
sharing the same allele identical-by-descent (IBD) among
all affected family members [S6]. The reported logarithm
of odds ratio (LOD) score is calculated as LOD =
Zlr2/2ln10. In some instances, families of different ethnic
groups were extracted from the master linkage file and
analyzed separately. Allele frequencies used in the para-
meter files for each analysis were generated from the
founder genotypes for the analyzed set of data (sibpair
families, trio families, all families combined, and individual
ethnic groups).
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The alleles from the 11-marker fine map were examined for
the presence of transmission disequilibrium using the
transmission disequilibrium test (TDT) [S7] and the discor-
dant sibling TDT (S-TDT) test [S8]. Analysis was con-
ducted using the combined TDT/S-TDT program version
1.1, set to accept one missing parent per trio [S8]. This
program outputs separate results for the TDT, S-TDT and
the combined TDT/S-TDT (referred to herein as C-TDT). In
families with multiple affected individuals, only a single
affected patient (the index case) was used for the TDT
and C-TDT analyses.
Two- and three-marker haplotypes from the 1q32–41
region were tested for the presence of transmission dise-
quilibrium. Maximum-likelihood haplotypes were generated
using GENEHUNTER PLUS for the 274 families with at
least one typed parent. Markers where phase could not be
definitively determined were identified and labeled as
missing data for the haplotype analysis. Founder haplo-
types were then used to create two- and three-contigu-
ous-marker exact-match clusters using a moving-window
approach, as described by Nair et al [S9]. In order to
prevent rare haplotypes from dominating the statistical
tests and to better approximate the distributional assump-
tions of these tests, only those haplotypes with at least 10
founders were clustered. Haplotypes represented in fewer
than 10 founders were pooled together. Every two- or
three-marker ‘window’ was examined by moving the
window across the 1q32–42 region one marker at a time
from centromere to telomere. The resulting haplotype data
were examined using the TDT and C-TDT with each haplo-
type considered as a single marker.
Additional information from the sibpair and multiplex fami-
lies was extracted using the pedigree disequilibrium test
(PDT) [S10]. The original form of the PDT incorporates
information from every possible triad and discordant sib-
ship in a given family, to yield an average measure of dise-
quilibrium for the entire pedigree. In addition, we analyzed
dyads (one parent and an affected offspring) when the
offspring had a heterozygous genotype different from that
of the parent [S11,S12]. The PDT was used to examine
the single-marker and the two- and three-marker haplo-
type data.
Linkage analysis in families carrying ‘risk’ haplotypes
GENEHUNTER PLUS creates maximum-likelihood haplo-
types when conducting multipoint linkage analysis. The
GENEHUNTER PLUS haplotype output was used to iden-
tify families with founders carrying the seven three-marker
haplotypes in the 1q41 region (D1S229–D1S2641) that
had a TDT transmission:nontransmission ratio of at least
2:1 (66% transmission rate). Multipoint linkage analysis
was conducted on the ‘risk’ and ‘nonrisk’ subsets as
described above.
Supplementary results
Clinical features of systemic lupus erythematosus (SLE) in
sibpair and trio families
The composition of the sibpair families studied in this
report is summarized in Supplementary Table 1 (see
below). Twenty-four additional families were included
beyond the families that comprised the original Min-
nesota Cohorts 1 and 2 [S13,S14]. In addition, a collec-
tion of 122 trio families (one SLE patient with both
parents) was assembled. Demographics and selected
clinical characteristics of the affected individuals within
the sibpair and trio collections are presented in Supple-
mentary Table 2. The trio collection was highly enriched
for white families (96% compared with 77% in the
sibpair families). Compared with patients from the sibpair
collection, trio individuals were more likely to be positive
for anti-dsDNA antibody, and to have evidence of hema-
tologic or renal disease. Lower percentages of trio
patients had pleuritis, skin involvement, or CNS lupus.
The differences in the clinical manifestations observed
may reflect the greater ethnic diversity within the sibpair
collection as well as potential differences in familial com-
pared with sporadic SLE.
Linkage analysis in families carrying ‘risk’ haplotypes
The evidence for linkage was examined in the subset of
families that carried the ‘risk’ haplotypes, defined as those
families carrying three-marker haplotypes from D1S229 to
D1S2641 that displayed at least a 2:1 transmission:non-
transmission ratio (see Fig. 3 in the main text of this
article). Families with the 1q41 risk haplotypes (n = 88)
demonstrated a multipoint LOD score of 1.15 at
D1S2616, while the remainder of the family collection
(n = 23) showed a LOD score at D1S2616 of 0.30. Thus,
SLE families carrying the ‘risk’ marker haplotypes with the
strongest evidence for transmission disequilibrium were
also the families that accounted for most of the evidence
for linkage in the 1q41 region.
Localization of the 1q41 effect through haplotype analysis
The two most significant three-marker haplotypes identified
in the moving-window analysis were D1S229–allele
7/D1S490–allele 7/D1S227–allele 5 and D1S2616–allele
6/D1S549–allele 12/D1S2641–allele 10. Interestingly,
none of the 83 individuals who carried one of these two
haplotypes contained both of these on a further extended
haplotype. Furthermore, 33 of 55 patients with the
229/490/227 haplotype (60%) also bore allele 6 of
D1S2616, while 14 of 28 individuals with the
2616/549/2641 haplotype also bore allele 5 of D1S227.
This suggests the possibility that the major effect in this
region is between markers D1S227 and D1S2616, an
interval of approximately 0.96 megabasepairs. Alternatively,
there might be two effects in the region, each carried on
one of the haplotypes. The two-marker haplotype data
provide some support for the former interpretation, since the
Arthritis Research    Vol 3 No 5 Graham et alpeak number of significant haplotype transmissions is found
within the D1S227–D1S2616 interval, with the number of
events falling off at surrounding windows. Although the
current evidence for linkage disequilibrium at 1q41 extends
over quite a broad interval, it is important to note that the
marker density in the current study is still rather sparse.
Efforts to further localize the gene in this region will require
the identification and typing of additional microsatellite
markers and single nucleotide polymorphisms (SNPs) in a
large cohort of SLE cases and controls.
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Supplementary Table 1
Composition of 210 Minnesota SLE sibpair and multiplex
families
Cohort 1 Cohort 2 New Total
SLE families 104 82 24 210
Affected sibpairs 114 93 26 233
Affected relative pairs 127 111 35 273
Affected SLE individuals 220 179 53 452
Unaffected parents and sibs 155 101 41 297
Supplementary Table 2
Demographics and clinical features of 576 SLE patients
Sibpair Trio
Number of families 210 122
Number of affected individuals (sex, F:M) 440:10 123:0
Family ethnicity
White 78 96
African-American 10 1
Hispanic 7 1
Asian 2 1
Mixed heritage 3 1
Laboratory/clinical features† (%)
ANA positive 98 97
Anti-dsDNA positive 46 72***
Arthritis 85 84
Skin involvement 92 82**
Pleuritis 53 45*
Hematologic 48 72***
Renal disease 33 53***
CNS lupus 25 15**
Pericarditis 19 20
†Data represent the percentage of SLE patients having the indicated
laboratory/clinical features at any time during the course of their
disease. Differences in the clinical features between the trio and
sibpair familiy collections were determined using generalized
estimating equations to adjust for intrafamilial correlation within the
sibpair families [S15]. ***P < 0.0001, **P < 0.01, *P < 0.05. 
ANA = antinuclear antibodies; CNS = central nervous system